Federal contract award
75N95025P00257
PLASMA ASSAYS OF ALZHEIMER'S DISEASE BIOMARKERS (ABETA42, ABETA40, PTAU217) USING THE LUMIPULSE ASSAYS ON THE FUJIREBIO G1200 IN THE BALTIMORE LONGITUDINAL STUDY OF AGING (BLSA)
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIDA |
| NAICS | 621511 — Medical Laboratories |
| PSC | Q301 — Reference Laboratory Testing |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $64.9K |
| Current contract value | $64.9K |
| Potential contract value / ceiling | $64.9K |
| Start date | May 1, 2025 |
| Current end date | Apr 30, 2026 |
| Potential end date | Apr 30, 2026 |
| Latest award activity | Apr 29, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Apr 29, 2025 | 0 | $64.9K | PLASMA ASSAYS OF ALZHEIMER'S DISEASE BIOMARKERS (ABETA42, ABETA40, PTAU217) USING THE LUMIPULSE ASSAYS ON THE FUJIREBIO G1200 IN THE BALTIMORE LONGITUDINAL STUDY OF AGING (BLSA) |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.